Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Update Il y a 4 ans
Reference: NCT00755833

Woman and Man

  • | Country :
  • Slovenia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control when using NovoMix® 50 up to 12 months after initiation subjects with type 2 diabetes currently on a therapy with human biphasic insulin. An additional objective is also to observe the different regimes of starting and maintaining the treatment with NovoMix® 50 during one year.


Inclusion criteria

  • diabetes ,Diabetes Mellitus, Type 2

Links